Stephen Gange
#100,541
Most Influential Person Now
American epidemiologist and academic administrator
Stephen Gange's AcademicInfluence.com Rankings
Stephen Gangemedical Degrees
Medical
#3488
World Rank
#3958
Historical Rank
Epidemiology
#674
World Rank
#700
Historical Rank
Download Badge
Medical
Stephen Gange's Degrees
- Masters Epidemiology University of California, Berkeley
- PhD Epidemiology University of California, Berkeley
Why Is Stephen Gange Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephen Gange is an American statistician, epidemiologist, and academic administrator of Johns Hopkins University. He is a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health and has a joint appointment in the Johns Hopkins School of Medicine.
Stephen Gange's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy (1999) (2106)
- Epidemiology and estimated population burden of selected autoimmune diseases in the United States. (1997) (1508)
- Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells (2003) (1484)
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada (2013) (1190)
- Effect of early versus deferred antiretroviral therapy for HIV on survival. (2009) (1170)
- Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection (1999) (994)
- Competing risk regression models for epidemiologic data. (2009) (990)
- The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench (2005) (514)
- Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy (2009) (443)
- Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. (2003) (385)
- Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer (2001) (304)
- A survey of methods for analyzing clustered binary response data (1996) (290)
- Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China (2005) (283)
- T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women (2011) (273)
- Driving status and risk of entry into long-term care in older adults. (2006) (273)
- Predictors of proteinuria and renal failure among women with HIV infection. (2002) (264)
- Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men (2008) (258)
- Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. (2015) (243)
- Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. (2006) (240)
- Ten-year predicted coronary heart disease risk in HIV-infected men and women. (2007) (238)
- Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. (2010) (224)
- Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. (2003) (221)
- Late presentation for human immunodeficiency virus care in the United States and Canada. (2010) (215)
- C-reactive protein is a marker for human immunodeficiency virus disease progression. (2006) (206)
- Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study (2013) (193)
- Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. (2007) (190)
- Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis (2013) (189)
- Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. (2004) (189)
- Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication (2002) (179)
- Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). (2007) (178)
- Determinants of graft survival after renal transplantation. (1996) (177)
- Cohort Profile: The Women's Interagency HIV Study (WIHS). (2018) (176)
- Random survival forests for competing risks. (2014) (173)
- Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study (2004) (165)
- Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda (2003) (165)
- The Association of Race, Sociodemographic, and Behavioral Characteristics With Response to Highly Active Antiretroviral Therapy in Women (2005) (159)
- Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. (2007) (154)
- Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. (1996) (154)
- Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004 (2005) (152)
- Incidence of Oral Lesions in HIV-1-infected Women: Reduction with HAART (2004) (142)
- Physical and psychosocial side effects of antepartum hospital bed rest. (1993) (139)
- Prevalence and Correlates of Anemia in a Large Cohort of HIV‐Infected Women: Women's Interagency HIV Study (2001) (139)
- Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. (2004) (138)
- Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure (2002) (135)
- Retention Among North American HIV-Infected Persons in Clinical Care, 2000–2008 (2013) (135)
- Risk of Non-AIDS-Related Mortality May Exceed Risk of AIDS-Related Mortality Among Individuals Enrolling Into Care With CD4+ Counts Greater Than 200 Cells/mm3 (2007) (134)
- Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. (2004) (133)
- Association of Race and Gender With HIV‐1 RNA Levels and Immunologic Progression (2000) (132)
- The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women (2011) (121)
- Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. (2011) (121)
- Virologic and immunologic response to HAART, by age and regimen class (2010) (120)
- Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. (2009) (119)
- T cell activation predicts carotid artery stiffness among HIV-infected women. (2011) (116)
- Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States (2018) (115)
- Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. (2016) (114)
- The parametric g‐formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death (2012) (114)
- Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. (2012) (111)
- Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia (2010) (107)
- U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008 (2012) (106)
- Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada (2020) (104)
- Marginal and Mixed-Effects Models in the Analysis of Human Papillomavirus Natural History Data (2010) (101)
- Changes in sexual behavior among HIV-infected women after initiation of HAART. (2004) (100)
- Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. (2006) (99)
- HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis. (2015) (96)
- Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. (2013) (96)
- Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs (2018) (96)
- Protease inhibitor levels in hair strongly predict virologic response to treatment (2009) (95)
- Generating Multivariate Categorical Variates Using the Iterative Proportional Fitting Algorithm (1995) (95)
- Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population (2017) (94)
- Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols (2005) (90)
- The Prognostic Importance of Changes in CD4+ Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy (2004) (86)
- CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? (2010) (86)
- Regulatory CD4+ T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein B. (2018) (83)
- Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men (2017) (81)
- Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. (2011) (80)
- Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study* (2000) (77)
- Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. (2019) (76)
- Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. (2000) (75)
- Effectiveness of highly active antiretroviral therapy among HIV-1 infected women (2002) (75)
- Outcomes After Treatment of Cervical Intraepithelial Neoplasia Among Women With HIV (2007) (71)
- Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study (2010) (71)
- Common clinical conditions – age, low BMI, ritonavir use, mild renal impairment – affect tenofovir pharmacokinetics in a large cohort of HIV-infected women (2014) (67)
- Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. (2004) (67)
- Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study (2000) (66)
- Serum Albumin Is a Powerful Predictor of Survival Among HIV‐1‐Infected Women (2003) (65)
- Assessing the effect of HAART on change in quality of life among HIV-infected women (2006) (64)
- Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. (2009) (64)
- Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment (2012) (63)
- Impact of Inversion of the CD4/CD8 Ratio on the Natural History of HIV-1 Infection (2006) (63)
- The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. (2011) (62)
- Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy. (2007) (62)
- Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. (2014) (62)
- Aging effects on accommodation and outflow facility responses to pilocarpine in humans. (1996) (61)
- Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. (2003) (61)
- A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. (2012) (59)
- Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America (2017) (59)
- Association of race and gender with HIV-1 RNA levels and immunologic progression. (2000) (58)
- Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. (2011) (56)
- Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan. (2011) (56)
- Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. (1997) (55)
- Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008) (55)
- Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis. (2000) (55)
- Interval and clinical cohort studies: epidemiological issues. (2007) (54)
- Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. (2004) (53)
- Disparities among US states in HIV-related mortality in persons with HIV infection, 2001–2007 (2012) (53)
- Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda (2008) (53)
- Distinguishing efficacy, individual effectiveness and population effectiveness of therapies. (2000) (51)
- Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. (2005) (51)
- Effectiveness of highly-active antiretroviral therapy by race/ethnicity (2006) (50)
- Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis (2012) (48)
- First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000–2013 (2016) (47)
- Geographic Variations in Retention in Care among HIV-Infected Adults in the United States (2016) (47)
- Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women--The Women's Interagency HIV Study. (2016) (47)
- Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. (2009) (46)
- CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. (2009) (46)
- Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. (1995) (44)
- Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients (2015) (43)
- Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS). (2001) (43)
- Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women (2009) (43)
- Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV (2018) (43)
- Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada (2017) (42)
- Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. (2005) (41)
- The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in HIV-Infected Women (2010) (40)
- Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. (2018) (39)
- Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. (2009) (39)
- Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. (2006) (38)
- Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. (2011) (38)
- Regulatory CD4+ T Cells Recognize MHC-II-Restricted Peptide Epitopes of Apolipoprotein B (2018) (38)
- CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. (2003) (38)
- Methodological issues for biomarkers and intermediate outcomes in cohort studies. (1998) (38)
- Use of Total Lymphocyte Count and Hemoglobin Concentration for Monitoring Progression of HIV Infection (2005) (38)
- Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy (2003) (38)
- Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda (2006) (37)
- Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations (2006) (37)
- Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women (2017) (37)
- The Effect of Sexual and Physical Violence on Risky Sexual Behavior and STDs Among a Cohort of HIV Seropositive Women (2001) (37)
- A comparison of methods for correlated ordinal measures with ophthalmic applications. (1995) (36)
- Use of the Beta‐Binomial Distribution to Model the Effect of Policy Changes on Appropriateness of Hospital Stays (1996) (36)
- Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression (2017) (36)
- Dissatisfaction with medical care among women with HIV: Dimensions and associated factors (2003) (35)
- Dependence of the hazard of AIDS on markers (1997) (35)
- The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. (2004) (35)
- Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. (2007) (34)
- Host APOL1 genotype is independently associated with proteinuria in HIV infection (2013) (33)
- Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
- Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time‐dependent hazards and delayed entry (2011) (32)
- Strategies for chemoprevention of liver cancer. (2002) (31)
- Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men (2003) (31)
- Systemic hypertension produces pericyte changes in retinal capillaries. (1993) (31)
- Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS. (1998) (31)
- High-Risk Behavior and Potential Transmission of Drug-Resistant HIV Among Injection Drug Users (2004) (30)
- The Effect of HAART on HIV RNA Trajectory Among Treatment-naïve Men and Women: A Segmental Bernoulli/Lognormal Random Effects Model With Left Censoring (2010) (30)
- Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission. (1996) (29)
- Incidence of violence against HIV-infected and uninfected women: Findings from the HIV epidemiology research (HER) study (2002) (29)
- Nonnucleoside Reverse Transcriptase Inhibitor Pharmacokinetics in a Large Unselected Cohort of HIV-Infected Women (2009) (29)
- Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. (2009) (29)
- Ocular renin angiotensin: EM immunocytochemical localization of prorenin. (1993) (28)
- Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection. (1998) (28)
- Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History (2008) (27)
- Prevalence and Correlates of Highly Active Antiretroviral Therapy Switching in the Women's Interagency HIV Study (2002) (27)
- Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001–2009 (2013) (27)
- Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model. (2005) (26)
- Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda (2008) (26)
- Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts (2007) (26)
- Strong Agreement of Nationally Recommended Retention Measures from the Institute of Medicine and Department of Health and Human Services (2014) (25)
- Consistency of Initial Antiretroviral Therapy With HIV Treatment Guidelines in a US Cohort of HIV-Infected Women (2008) (25)
- Underutilization of Statins When Indicated in HIV‐Seropositive and Seronegative Women (2017) (24)
- Sequential monitoring of clinical trials with correlated responses (1996) (24)
- Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection (2019) (23)
- Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. (2010) (23)
- Outcome After Negative Colposcopy Among Human Immunodeficiency Virus–Infected Women With Borderline Cytologic Abnormalities (2005) (23)
- Evaluating competing adverse and beneficial outcomes using a mixture model (2008) (23)
- Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model (2019) (23)
- Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy (2011) (22)
- The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV study. (2000) (22)
- Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. (2015) (22)
- Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS). (2007) (22)
- Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure. (2006) (22)
- Determinants of Newly Detected Human Papillomavirus Infection in HIV-Infected and HIV-Uninfected Injection Drug Using Women (2009) (21)
- Identifying the appropriate comparison group for HIV-infected individuals. (2014) (21)
- From Smallpox to Big Data: The Next 100 Years of Epidemiologic Methods. (2016) (21)
- Echolucency of the Carotid Artery Intima‐Media Complex and Intima‐Media Thickness Have Different Cardiovascular Risk Factor Relationships: The Women's Interagency HIV Study (2015) (21)
- Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy (2004) (21)
- Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression. (2001) (20)
- The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. (2011) (20)
- Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group. (2000) (19)
- Variability of molecular biomarker measurements from nonlinear calibration curves. (1996) (19)
- Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons. (2010) (18)
- Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data (2010) (18)
- Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys. (1996) (18)
- Carotid artery atherosclerosis is associated with mortality in HIV-positive women and men (2018) (18)
- Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999–2007 (2011) (18)
- An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004. (2010) (17)
- Superior cervical ganglionectomy in monkeys: aqueous humor dynamics and their responses to drugs. (1995) (17)
- Lower liver‐related death in African‐American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women (2012) (17)
- Serum effects on aqueous outflow during anterior chamber perfusion in monkeys. (1996) (16)
- Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection. (2012) (16)
- Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers (2010) (15)
- Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women’s Interagency HIV Study (2017) (15)
- Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. (2012) (15)
- Computer-aided assessment of diagnostic images for epidemiological research (2009) (15)
- Human leucocyte antigen class I and II imputation in a multiracial population (2016) (14)
- Genotypic Resistance and Immunologic Outcomes Among HIV-1-Infected Women With Viral Failure (2006) (14)
- Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design (2015) (13)
- AIDS onset at high CD4+ cell levels is associated with high HIV load. (2000) (13)
- Genome-wide admixture and association study of subclinical atherosclerosis in the Women’s Interagency HIV Study (WIHS) (2017) (13)
- Relation of HLA Class I and II Supertypes with Spontaneous Clearance of Hepatitis C Virus (2013) (13)
- Health-related Quality of Life Among People with HIV Disease (2000) (13)
- Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women. (2008) (12)
- Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women (2011) (12)
- The Changing Science of HIV Epidemiology in the United States (2019) (12)
- Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. (2011) (12)
- The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury—The Women’s Interagency HIV Study (2017) (11)
- Evaluation of Human Immunodeficiency Virus Biomarkers: Inferences From Interval and Clinical Cohort Studies (2009) (11)
- One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States (2018) (11)
- Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis (2021) (11)
- Parametric models to assess tracking of categorical high-risk sexual behaviour for HIV infection. (1996) (11)
- Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women (2007) (11)
- Application of case-crossover and case-time-control study designs in analyses of time-varying predictors of T-cell homeostasis failure. (2005) (10)
- Retrospective Mortality Study Among Employees Occupationally Exposed to Toner (2010) (10)
- Multimorbidity Among Persons Living with HIV in the U.S. (2017) (10)
- Teaching epidemiologic methods. (2008) (10)
- Loss of CXCR4 on non-classical monocytes in participants of the Women’s Interagency HIV Study (WIHS) with subclinical atherosclerosis (2018) (10)
- Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study. (2019) (10)
- Predisposing Factors for Adrenal Insufficiency (2009) (10)
- Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. (2008) (9)
- Vitamin A deficiency and genital viral burden in women infected with HIV-1 (2002) (9)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- Examining the Relationships Between Experienced and Anticipated Stigma in Health Care Settings, Patient-Provider Race Concordance, and Trust in Providers Among Women Living with HIV. (2021) (9)
- CCR2 genotype and disease progression in a treated population of HIV type 1-infected women. (2004) (9)
- Quantitative and qualitative correlates of cervicovaginal herpes simplex virus type 2 shedding among HIV-infected women in the Women's Interagency HIV Study (2011) (9)
- Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data. (2019) (8)
- Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with HIV. (2020) (8)
- Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV (2017) (8)
- Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens (2009) (8)
- Comparison of Goldmann Tonometry Measurements Using Creamer vs Fluorescein in Cynomolgus Monkeys (1997) (8)
- Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study (2013) (8)
- Epidemiologic Analysis: A Case-Oriented Approach (2002) (8)
- Combined analysis of retrospective and prospective occurrences in cohort studies: HIV-1 serostatus and incident pneumonia. (2006) (7)
- Systemic Cytokine Levels Do Not Predict CD4+ T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection (2016) (7)
- Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes (2015) (7)
- Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formula. (2017) (7)
- Classical Monocyte Transcriptomes Reveal Significant Anti-Inflammatory Statin Effect in Women with Chronic HIV. (2020) (6)
- Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study. (2002) (6)
- Patient Health Literacy and Communication with Providers among Women living with HIV: A Mixed Methods Study (2021) (6)
- Methods for the Analysis of Continuous Biomarker Assay Data With Increased Sensitivity (2004) (6)
- Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease (2022) (6)
- Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women (2019) (6)
- Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene (2009) (6)
- Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation. (1994) (6)
- First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013. (2016) (5)
- History of Incarceration Among Women with HIV: Impact on Prognosis and Mortality. (2019) (5)
- Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women. (2017) (5)
- Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms (2006) (4)
- Elevated caspase-3 expression and T-cell activation in elite suppressors. (2010) (4)
- e-Aminocaproic Acid Does Not Inhibit Outflow Resistance Washout in Monkeys (1995) (4)
- Methods for Comparing Correlations Involving Left-Censored Laboratory Data (2002) (4)
- Prevalence and correlates of restless legs syndrome in men living with HIV (2021) (4)
- Antiretroviral-treated HIV-infected women have similar long-term kidney function trajectories as HIV-uninfected women. (2013) (4)
- Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects (2016) (4)
- Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection (1994) (4)
- Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability (2011) (4)
- An Instrumental Variable Evaluation of Antidepressant Use on Employment Among Hiv-Infected Women Using Highly-Active Antiretroviral Therapy in the United States: 1996-2004 (2006) (3)
- Brief Report: Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIV (2021) (3)
- Estimation and inference on correlations between biomarkers with repeated measures and left‐censoring due to minimum detection levels (2012) (3)
- The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women (2008) (3)
- Correlated Binary Data (2005) (3)
- Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women (2014) (3)
- HIV Viral Load Trajectory among Treatment Naive Men and Women Initiating Long-Term Haart: An Application Using a Segmental Bernoulli/Lognormal Random Effects Model with Left Censoring (2006) (2)
- Restriction of HIV-1 infection in sickle cell trait (2021) (2)
- A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women (2020) (2)
- epsilon-Aminocaproic acid does not inhibit outflow resistance washout in monkeys. (1995) (2)
- Assessment of Different Classification Schemes for Identification of Diastolic Dysfunction in the Women's Interagency HIV Study. (2019) (2)
- Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study (2010) (2)
- A Genome‐Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair (2018) (2)
- Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV‐Infected Women (2020) (2)
- Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine (2020) (2)
- T-cell immune dysregulation and mortality in women with HIV. (2021) (1)
- Lung Function in Women With and Without Human Immunodeficiency Virus (2022) (1)
- Track C Epidemiology and Prevention Science (2012) (1)
- Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America. (2021) (1)
- CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2020) (1)
- Parametric models for studying time to antiretroviral resistance associated with illicit drug use. (2009) (1)
- Practice of Epidemiology Competing Risk Regression Models for Epidemiologic Data (2009) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large in (2020) (1)
- Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment. (2022) (1)
- Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval–Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection (2019) (1)
- Lung Function in Women with and without HIV. (2022) (1)
- Human Leukocyte Antigen (HLA) Genotype and Risk of HIV Disease (2011) (1)
- Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women. (2017) (1)
- Gange, S. J. (1995), “Generating multivariate categorical variates using the iterative proportional fitting algorithm,” the american statistician, 49,134-138: Comments by schulman and reply (1996) (1)
- BMI <22.5 and >25 predicted higher overall mortality in adults (2009) (0)
- Control of HIV-1 Infection By Ferroportin Q248H Mutation (2019) (0)
- Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection in the Women’s Interagency HIV Study (1994–2015) (2021) (0)
- Renal markers that predict poor outcomes in HIV-infected women (2005) (0)
- Abstract 11650: Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Atherosclerosis in HIV-infected Women and Men (2016) (0)
- Risk of HPV in Early HIV Infection Among Zimbabwean Women (2009) (0)
- Abstract P322: Association of Hiv Infection With Carotid Artery Plaque Echomorphology in the Women’s Interagency HIV Study (wihs) (2020) (0)
- P728 Correlates of syphilis in women living with and without HIV in the US women’s interagency HIV study (WIHS) (2019) (0)
- Definition of proteinuria among women with HIV infection. (2004) (0)
- Differences in Muscle Quantity and Quality by HIV Serostatus and Sex (2022) (0)
- Abstract 16803: Subclinical Atherosclerosis is Associated With Loss Of CXCR4 Surface Marker Expression on Non-classical Monocytes in HIV-infected Women (2016) (0)
- Translating molecular targets for chemoprevention into interventions for at-risk populations (2007) (0)
- Glucocorticoid Receptor Function and Cognitive Performance in Women With HIV (2022) (0)
- TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
- chronic HIV infection (2016) (0)
- 12S Sequential monitoring of clinical trials with correlated categorical data (1994) (0)
- Association of aspects of vision and quality-of-life in patients with subfoveal choroidal neovascularization (1997) (0)
- Resilience and Optimism as Moderators of the Negative Effects of Stigma on Women Living with HIV. (2022) (0)
- Visualizing the Geography of HIV Observational Cohorts With Density-Adjusted Cartograms (2021) (0)
- Abstract P323: HIV- and Subclinical Cardiovascular Disease-specific Transcriptomes in Nonclassical Monocytes: The Women’s Interagency HIV Study (2020) (0)
- Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy (cid:1) ‡ (2011) (0)
- Abstract 410: Statin Use May Alleviate Coagulation- and Inflammation-associated Gene Expression in Circulating Classical Monocytes in Women With Chronic HIV-1 Infection (2018) (0)
- Clarification and correction (2012) (0)
- 259: CD4 T-Cell Trajectory Among HIV-Infected Men and Women on Long Term Highly Active Antiretroviral Therapy: An Application using a Bayesian Random Change Point Model (2005) (0)
- Track B Clinical Science (2012) (0)
- T-cell activation state differentially contributes to neuropsychiatric complications in women with HIV (2022) (0)
This paper list is powered by the following services:
Other Resources About Stephen Gange
What Schools Are Affiliated With Stephen Gange?
Stephen Gange is affiliated with the following schools:
